The world's first clinical trial designed to explore using a hallucinogen from magic mushrooms to treat people with depression has stalled because of British and European rules on the use of illegal drugs in research.
David Nutt, president of the British Neuroscience Association and professor of neuropsychopharmacology at Imperial College London, said he had been granted an ethical green light and funding for the trial, but regulations were blocking it.
"We live in a world of insanity in terms of regulating drugs," he told a neuroscience conference in London on Sunday.
Read more »



Recent comments
9 hours 39 min ago
9 hours 40 min ago
9 hours 41 min ago
9 hours 41 min ago
9 hours 42 min ago
23 hours 33 min ago
1 day 6 hours ago
1 day 8 hours ago
4 days 11 hours ago
4 days 11 hours ago